MICROSPHERES AND NANOPARTICLES USED IN OCULAR DELIVERY SYSTEMS

被引:279
作者
ZIMMER, A [1 ]
KREUTER, J [1 ]
机构
[1] UNIV FRANKFURT,BIOCTR,INST PHARMACEUT TECHNOL,D-60439 FRANKFURT,GERMANY
关键词
EYE; DRUG DELIVERY; NANOPARTICLE; NANOSPHERE; MICROPARTICLES; MICROSPHERE; GLAUCOMA; PILOCARPINE; BETA-BLOCKER; HYDROCORTISONE;
D O I
10.1016/0169-409X(95)00017-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Microparticles and nanoparticles are colloidal drug carriers in the micro- and submicron range. These systems were developed to overcome solubility problems of poorly soluble drugs as well as for long acting injectable depot formulations and specific drug targeting options. These carriers were also evaluated for ophthalmic drug delivery purposes over the past 15 years. The main objective for these systems was to improve the classical aqueous eye drop formulations which have major disadvantages like a rapid elimination of the drugs from the precorneal area. Consequently, colloidal carrier suspensions were designed to combine ophthalmic prolonged action with the ease of the application of liquid eye drops. The review summarises the present manufacturing methods and the materials used for these delivery systems with respect to ophthalmic purposes. The distribution and penetration pathways of the particulate delivery systems are also described. The applications of drug-loaded particles are presented with focus on ophthalmic diseases like glaucoma, inflammations or infections of the eye. Accordingly, particulate carriers outlined in the review include systems loaded with pilocarpine, beta-blockers, hydrocortisone, amikacin, and miscellaneous drugs. Finally, the biodegradation and toxicity of the carrier materials under evaluation are reviewed.
引用
收藏
页码:61 / 73
页数:13
相关论文
共 81 条
[71]  
WIDDER KJ, 1985, METHODS ENZYMOLOGY, V112
[72]   OCULAR DISPOSITION OF POLY-HEXYL-2-CYANO[3-C-14]ACRYLATE NANOPARTICLES IN THE ALBINO RABBIT [J].
WOOD, RW ;
LI, VHK ;
KREUTER, J ;
ROBINSON, JR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 23 (02) :175-183
[73]   PHARMACOKINETIC AND PHARMACODYNAMIC ASPECTS OF AN OPHTHALMIC PILOCARPINE NANOPARTICLE-DELIVERY-SYSTEM [J].
ZIMMER, A ;
MUTSCHLER, E ;
LAMBRECHT, G ;
MAYER, D ;
KREUTER, J .
PHARMACEUTICAL RESEARCH, 1994, 11 (10) :1435-1442
[74]   STUDIES ON THE TRANSPORT PATHWAY OF PBCA NANOPARTICLES IN OCULAR-TISSUES [J].
ZIMMER, A ;
KREUTER, J ;
ROBINSON, JR .
JOURNAL OF MICROENCAPSULATION, 1991, 8 (04) :497-504
[75]  
ZIMMER A, 1990, PHARMACEUT RES, V7, pS114
[76]   EVALUATION OF PILOCARPINE-LOADED ALBUMIN PARTICLES AS DRUG-DELIVERY SYSTEMS FOR CONTROLLED DELIVERY IN THE EYE .1. IN-VITRO AND IN-VIVO CHARACTERIZATION [J].
ZIMMER, AK ;
ZERBE, H ;
KREUTER, J .
JOURNAL OF CONTROLLED RELEASE, 1994, 32 (01) :57-70
[77]   HYDROCORTISONE DELIVERY TO HEALTHY AND INFLAMED EYES USING A MICELLAR POLYSORBATE-80 SOLUTION OR ALBUMIN NANOPARTICLES [J].
ZIMMER, AK ;
MAINCENT, P ;
THOUVENOT, P ;
KREUTER, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 110 (03) :211-222
[78]   EVALUATION OF PILOCARPINE-LOADED ALBUMIN PARTICLES AS CONTROLLED DRUG-DELIVERY SYSTEMS FOR THE EYE .2. COADMINISTRATION WITH BIOADHESIVE AND VISCOUS POLYMERS [J].
ZIMMER, AK ;
CHETONI, P ;
SAETTONE, MF ;
ZERBE, H ;
KREUTER, J .
JOURNAL OF CONTROLLED RELEASE, 1995, 33 (01) :31-46
[79]  
ZIMMER AK, 1991, P S CONTROL REL MATE, V18, P493
[80]  
1982, Patent No. 4357259